BEAUTYFARM MED (02373) Non-Executive Director Li Fangyu Increases Stake by 41,500 Shares

Stock News12-01

BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Li Fangyu, has notified the company of her increased stake. On December 1, 2025, she acquired 41,500 ordinary shares, representing approximately 0.02% of the total issued shares as of the announcement date. The shares were purchased in the open market through LIFY Management Holdings Limited. This move demonstrates her strong confidence in the group's future growth prospects.

Additionally, the company disclosed its share repurchase of 80,000 shares on December 1, 2025, totaling approximately HK$2.0008 million at an average price of HK$25.01 per share. From October 15 to December 1, 2025, the company has repurchased a cumulative 775,000 shares for about HK$22.6932 million.

The board believes the current share price does not reflect the intrinsic value of the company or its actual business potential. The repurchases signify management's confidence in long-term value creation and aim to enhance capital market valuation and shareholder returns. These actions align with the overall interests of the company and its shareholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142307152?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142307152","market":"other","top_or_hot":-1,"title":"BEAUTYFARM MED (02373) Non-Executive Director Li Fangyu Increases Stake by 41,500 Shares","media":"Stock News","content":"<p>BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Li Fangyu, has notified the company of her increased stake. On December 1, 2025, she acquired 41,500 ordinary shares, representing approximately 0.02% of the total issued shares as of the announcement date. The shares were purchased in the open market through LIFY Management Holdings Limited. This move demonstrates her strong confidence in the group's future growth prospects.</p>\n<p>Additionally, the company disclosed its share repurchase of 80,000 shares on December 1, 2025, totaling approximately HK$2.0008 million at an average price of HK$25.01 per share. From October 15 to December 1, 2025, the company has repurchased a cumulative 775,000 shares for about HK$22.6932 million.</p>\n<p>The board believes the current share price does not reflect the intrinsic value of the company or its actual business potential. The repurchases signify management's confidence in long-term value creation and aim to enhance capital market valuation and shareholder returns. These actions align with the overall interests of the company and its shareholders.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BEAUTYFARM MED (02373) Non-Executive Director Li Fangyu Increases Stake by 41,500 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBEAUTYFARM MED (02373) Non-Executive Director Li Fangyu Increases Stake by 41,500 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-01 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Li Fangyu, has notified the company of her increased stake. On December 1, 2025, she acquired 41,500 ordinary shares, representing approximately 0.02% of the total issued shares as of the announcement date. The shares were purchased in the open market through LIFY Management Holdings Limited. This move demonstrates her strong confidence in the group's future growth prospects.</p>\n<p>Additionally, the company disclosed its share repurchase of 80,000 shares on December 1, 2025, totaling approximately HK$2.0008 million at an average price of HK$25.01 per share. From October 15 to December 1, 2025, the company has repurchased a cumulative 775,000 shares for about HK$22.6932 million.</p>\n<p>The board believes the current share price does not reflect the intrinsic value of the company or its actual business potential. The repurchases signify management's confidence in long-term value creation and aim to enhance capital market valuation and shareholder returns. These actions align with the overall interests of the company and its shareholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02373","symbol_name":"美丽田园医疗健康","start_time":0,"source_url":"","article_id":"1142307152","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142307152","pubTimestamp":1764600855,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Li Fangyu, has notified the company of her increased stake. On December 1, 2025, she acquired 41,500 ordinary shares,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02373":"美丽田园医疗健康","BK1215":"特殊消费者服务"},"translate_title":"BEAUTYFARM MED(02373)非执行董事李芳瑜增持4.15万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02373":1},"content_text":"BEAUTYFARM MED (02373) announced that its non-executive director, Ms. Li Fangyu, has notified the company of her increased stake. On December 1, 2025, she acquired 41,500 ordinary shares, representing approximately 0.02% of the total issued shares as of the announcement date. The shares were purchased in the open market through LIFY Management Holdings Limited. This move demonstrates her strong confidence in the group's future growth prospects.\nAdditionally, the company disclosed its share repurchase of 80,000 shares on December 1, 2025, totaling approximately HK$2.0008 million at an average price of HK$25.01 per share. From October 15 to December 1, 2025, the company has repurchased a cumulative 775,000 shares for about HK$22.6932 million.\nThe board believes the current share price does not reflect the intrinsic value of the company or its actual business potential. The repurchases signify management's confidence in long-term value creation and aim to enhance capital market valuation and shareholder returns. These actions align with the overall interests of the company and its shareholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142307152","isCrawlerRequest":true}